Chromogranin A (CgA) in the Diagnosis and Monitoring of Patients with Gastroenteropancreatic (GEP) Neuroendocrine Tumors (NET): A Single-Institution Experience

被引：0
|
作者：
Massironi, S. [1 ]
Rossi, R. E.
Spampatti, M. P.
Casazza, G. [2 ]
Conte, D.
Ciafardini, C.
Cavalcoli, F.
Peracchi, M.
机构：
[1] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
[2] Univ Milan, Dept Clin Sci L Sacco, Milan, Italy
来源：
NEUROENDOCRINOLOGY | 2012年 / 96卷
关键词：
cga; gep-net;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：48 / 48
页数：1
相关论文
共 50 条
  • [41] Chromogranin A: a sensitive biomarker for the detection and post-treatment monitoring of gastroenteropancreatic neuroendocrine tumors
    Singh, Simron
    Law, Calvin
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (03) : 313 - 334
  • [42] SERUM CHROMOGRANIN-A IN THE DIAGNOSIS AND FOLLOW-UP OF NEUROENDOCRINE TUMORS OF THE GASTROENTEROPANCREATIC TRACT
    SCHURMANN, G
    RAETH, U
    WIEDENMANN, B
    BUHR, H
    HERFARTH, C
    WORLD JOURNAL OF SURGERY, 1992, 16 (04) : 697 - 702
  • [43] Gastroenteropancreatic neuroendocrine tumors: Incidence and treatment outcome in a single institution in Korea
    Lim, Taekyu
    Lee, Jeeyun
    Kim, Jae J.
    Lee, Jong Kyun
    Lee, Kyu Taek
    Kim, Young Ho
    Kim, Kwang-Won
    Kim, Sung
    Sohn, Tae Sung
    Choi, Dong Wook
    Choi, Seong Ho
    Chun, Ho-Kyung
    Lee, Woo Young
    Kim, Kyoung-Mee
    Jang, Kee-Taek
    Park, Young Suk
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (03) : 293 - 299
  • [44] Efficacy of Oral Chemotherapy with Capecitabine and Temozolomide (Captem) in Patients with Metastatic Neuroendocrine Tumors (NETS). A Single-Institution Experience
    Smiroldo, V
    Carnaghi, C.
    Lania, A.
    Bonifacio, C.
    Pepe, G.
    Zerbi, A.
    Rimassa, L.
    Lavezzi, E.
    Spaggiari, P.
    NEUROENDOCRINOLOGY, 2018, 106 : 206 - 206
  • [45] USE OF RADIOTHERAPY IN PATIENTS WITH GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NET) IN ITALY: A REAL-WORLD DATA ANALYSIS
    Sciattella, P.
    Scortichini, M.
    Mennini, F. S.
    VALUE IN HEALTH, 2022, 25 (12) : S457 - S457
  • [46] Symptomatic Presentation as a Predictor of Recurrence in Gastroenteropancreatic Neuroendocrine Tumors: A Single Institution Experience Over 15 Years
    Baptiste, G. G.
    Postlewait, L. M.
    Ethun, C. G.
    Le, N.
    McInnis, M. R.
    Russell, M. C.
    Winer, J. H.
    Kooby, D. A.
    Staley, C. A.
    Maithel, S. K.
    Cardona, K.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S156 - S156
  • [47] Symptomatic Presentation as a Predictor of Recurrence in Gastroenteropancreatic Neuroendocrine Tumors: A Single Institution Experience Over 15 Years
    Baptiste, Gillian G.
    Postlewait, Lauren M.
    Ethun, Cecilia G.
    Le, Nina
    Mcinnis, Mia R.
    Russell, Maria C.
    Winer, Joshua H.
    Kooby, David A.
    Staley, Charles A.
    Maithel, Shishir K.
    Cardona, Kenneth
    JOURNAL OF SURGICAL ONCOLOGY, 2016, 114 (02) : 163 - 169
  • [48] Expression of Target Molecules in Japanese Gastroenteropancreatic Neuroendocrine Tumours (GEP-NET) Patients
    Kasajima, A.
    Yazdanikivi, S.
    Sasano, H.
    JOURNAL OF PATHOLOGY, 2012, 228 : S36 - S36
  • [49] Neuroendocrine Tumors of the Kidney: A Single Institution Experience
    Teegavarapu, Purnima Sravanti
    Rao, Priya
    Matrana, Marc
    Cauley, Diana H.
    Wood, Christopher G.
    Tannir, Nizar M.
    CLINICAL GENITOURINARY CANCER, 2014, 12 (06) : 422 - 427
  • [50] Single Institution Experience With Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
    Duan, H.
    Ferri, V.
    Kunz, P.
    Davidzon, G.
    Nguyen, J.
    Moradi, F.
    Franc, B.
    Iagaru, A.
    Aparici, C. Mari
    PANCREAS, 2021, 50 (03) : 456 - 456
12345